Sentinel Initiative Needs Better Defined Goals, Outside Review Concludes
This article was originally published in The Pink Sheet Daily
Executive Summary
The Pharmacovigilance Review Subcommittee of FDA's Science Board reports a lack of clarity within CDER over just what purpose the drug safety program is supposed to serve.
You may also be interested in...
Adverse Events, Direct From The Consumer
FDA's proposed consumer version of the MedWatch form for reporting drug-related adverse events goes before an advisory panel.
Industry Seeks Bigger Role In Tackling Regulatory Science
The Biotechnology Industry Organization is pushing for a place at the table in shaping regulatory science.
Industry Seeks Bigger Role In Tackling Regulatory Science
The Biotechnology Industry Organization is pushing for a place at the table in shaping regulatory science.